출판 : MarketsandMarkets（마켓츠앤마켓츠）출판년월 : 2022년07월
임상 의사결정 지원 시스템(CDSS) 시장 : 컴포넌트(서비스, 소프트웨어), 배포(온프레미스, 클라우드), 제품(독립형, 통합), 애플리케이션(고도, 치료, 진단), 양방향(활성, 패시브) – 2027년까지의 세계 예측
Clinical Decision Support Systems (CDSS) Market by Component (Services, Software), Delivery (On-premise, Cloud), Product (Standalone, Integrated), Application (Advanced, Therapeutic, Diagnostic), Interactivity (Active, Passive) – Global Forecasts to 2027
| 페이지수 | 232 |
| 도표수 | 237 |
| 구성 | 영문조사보고서 |
| 가격 |
The global clinical decision support systems (CDSS) market is projected to reach USD 2.2 billion by 2027 from USD 1.5 billion in 2022, at a CAGR of 7.9% during the forecast period. The growth of this market is driven by the various government regulations and initiatives that are implemented to promote the adoption of HCIT solutions, increase in the adoption of CDSS integrated EHRs, growth in collaborations and partnerships between competitor companies, rgrowing incidence in medication errors, and the development of mHealth and big data tools.
세계 임상 의사 결정 지원 시스템(CDSS) 시장은 예측 기간 동안 7.9%의 CAGR로 2022년 15억 달러에서 2027년 22억 달러에 이를 것으로 예상됩니다.
이 시장의 성장은 HCIT 솔루션의 채택, CDSS 통합 EHR의 채택 증가, 경쟁 회사 간의 협력 및 파트너십 증가, 약물 오류 발생률 증가를 촉진하기 위해 구현되는 다양한 정부 규정 및 이니셔티브에 의해 주도됩니다. mHealth 및 빅 데이터 도구의 개발.
However, high investments for the implementation of CDSS and interoperability issues coupled with rising data security concerns are factors expected to restrain the growth of this market during the forecast period.
“Software segment is expected to grow at the highest rate during the forecast period”
On basis of component the CDSS market is segmented into : services, software, and hardware. In 2021, the services segment accounted for the largest share of this market. Growth in this segment is attributed to the recurring nature of the services such as training and development, installation, consulting, and maintenance.
“The On-premise solutions segment is estimated to account for the largest share of the Clinical decision support systems market in 2022”
On basis of delivery mode , Clinical decision support systems are delivered to end users through on-premise and cloud-based modes. The on-premise mode of delivery accounted for the largest share of the clinical decision support systems market in 2021. The cloud-based mode of delivery, on the other hand, is estimated to grow at the highest CAGR due to lower capital expenses and operational costs incurred in this model, alongside its scalability, flexibility, and affordability.
“Conventional CDSS segment accounted for the largest share of the global Clinical decision support systems market”
Based on application, the CDSS market is segmented into conventional CDSS and advanced CDSS. In 2021, the conventional CDSS segment accounted for the largest share of the market. Conventional CDSS has largest share in the market primarily due to the increasing adoption of CDSS by healthcare organizations to provide guidance & reminders to caregivers at the point-of-care.
“Integrated CDSS segment accounted for the largest share of the global Clinical decision support systems market”
Based on product, the CDSS market is segmented into integrated CDSS and standalone CDSS. In 2021, the integrated CDSS segment accounted for the largest share of the market. The large share of this segment can be attributed to the growing adoption of integrated CDSS in healthcare settings and organizations.
“The therapeutic CDSS segment is expected to grow with the highest CAGR during the forecast period”
Based on type, the clinical decision support systems market is segmented into therapeutic CDSS and diagnostic CDSS. The therapeutic CDSS segment dominated this market in 2021. This segment is estimated to grow at a higher CAGR during the forecast period. This segment’s large share and high growth rate can be attributed to factors such as therapeutic CDSS being preferred by clinicians over diagnostic CDSS as it is better compatible with clinical workflows. It is also convenient to use, as it doesn’t restrict the healthcare provider’s autonomy.
“Knowledge-based CDSS segment accounted for the largest share of the global Clinical decision support systems market”
Based on the model, the CDSS market is segmented into knowledge-based CDSS and non-knowledge-based CDSS. In 2021, the knowledge-based CDSS segment accounted for the largest share of the market. This segment is also estimated to register the highest CAGR during the forecast period. The large share and high growth of this segment can be attributed to the several benefits of these systems, such as helping clinicians with knowledge-based reasoning and to make clinical decisions in uncertainties. These systems can also be integrated into clinical workflows and are less prone to errors.
“The Active CDSS segment is expected to grow with the highest CAGR during the forecast period”
Based on the interactivity level, the CDSS market can be segmented into active CDSS and passive CDSS. The active CDSS segment accounted for the largest share of the market in 2021 and is projected to grow at the highest CAGR during the forecast period.
“Inpatient settings accounted for the largest share of the global Clinical decision support systems market”
Based on setting, the CDSS market is segmented into inpatient and ambulatory care settings. Inpatient settings accounted for the largest share of the CDSS market in 2021. Inpatient settings have to capture and analyze large volumes of patient data, this results in the increasing adoption of integrated healthcare IT modules.
“North America to dominate the Clinical decision support systems market in 2022”
North America accounted for the largest share of the global clinical decision support systems market in 2021. The large share of the North American market can be attributed to the noticeable investments in HCIT solutions, regulatory mandates that favor the implementation of CDSS, the presence of key market players in the region, and the rise in medication errors in the US and Canada.
The Asia Pacific market is projected to register the highest CAGR during the forecast period, owing to the factors such as the presence of a large geriatric population, improved government regulations, the high burden of chronic diseases, and the growing focus of various market players on emerging Asian countries are expected to drive the growth of the CDSS market in Asia.
Breakdown of supply-side primary interviews, by company type, designation, and region:
• By Company Type: Tier 1 (45%), Tier 2 (35%), and Tier 3 (20%)
• By Designation: C-level (26%), Director-level (17%), and Others (57%)
• By Region: North America (40%), Europe (20%), Asia Pacific (30%), and RoW (10%)
Prominent players operating in the CDSS market are Cerner Corporation (US), Change Healthcare (US), Epic Systems (US), MEDITECH (US), Philips Healthcare (Netherlands), Wolters Kluwer N.V. (Netherlands), Zynx Health (US), Elsevier B.V. (UK), IBM Watson Health (US), Allscripts Healthcare LLC (US), athenahealth (US), NextGen Healthcare (US), Siemens Healthineers (US), EBSCO Health (US), GE Healthcare (US), eClinicalWorks (US), RAMPMedical (Germany), The Medical Algorithms Company Limited (UK), Hera-MI (France), CureMD Healthcare (US), CareCloud, Inc (US), Visual DX (US), Stanson Health (US), First Databank, Inc (US), and Strata Decision Technology (US).
Research Coverage
• The report studies the Clinical decision support systems market based on component, delivery mode, product, model, interactivity level, application, setting, type, and region
• The report analyzes factors (such as drivers, restraints, opportunities, and challenges) affecting the market growth
• The report evaluates the opportunities and challenges in the market for stakeholders and provides details of the competitive landscape for market leaders
• The report studies micro-markets with respect to their growth trends, prospects, and contributions to the total Clinical decision support systems market
• The report forecasts the revenue of market segments with respect to five major regions
Key Benefits of Buying the Report:
The report will help the leaders/new entrants in this market with information on the closest approximations of the revenue numbers for the overall market and the sub-segments. This report will help stakeholders understand the competitive landscape and gain more insights to better position their businesses and plan suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the Clinical decision support systems market and provides them information on key market drivers, restraints, challenges, and opportunities.
목차
TABLE OF CONTENTS
1 INTRODUCTION (Page No. – 23)
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.2.1 CLINICAL DECISION SUPPORT SYSTEM MARKET: INCLUSIONS & EXCLUSIONS
1.3 MARKET SCOPE
1.3.1 MARKETS COVERED
FIGURE 1 CDSS MARKET SEGMENTATION
1.3.2 YEARS CONSIDERED FOR THE STUDY
1.4 CURRENCY
1.5 LIMITATIONS
1.5.1 SCOPE-RELATED LIMITATIONS
1.5.2 METHODOLOGY-RELATED LIMITATIONS
1.6 STAKEHOLDERS
1.7 SUMMARY OF CHANGES
2 RESEARCH METHODOLOGY (Page No. – 28)
2.1 RESEARCH DATA
FIGURE 2 RESEARCH DESIGN
2.1.1 SECONDARY DATA
2.1.1.1 Key data from secondary sources
2.1.2 PRIMARY RESEARCH
FIGURE 3 PRIMARY SOURCES
2.1.2.1 Key industry insights
FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
2.2 MARKET SIZE ESTIMATION METHODOLOGY
FIGURE 5 RESEARCH METHODOLOGY: HYPOTHESIS BUILDING
2.3 MARKET ESTIMATION
FIGURE 6 RESEARCH METHODOLOGY: MARKET ESTIMATION
2.3.1 APPROACH: END USER-BASED MARKET ESTIMATION
FIGURE 7 MARKET-SIZE ESTIMATION
2.4 MARKET DATA ESTIMATION AND TRIANGULATION
FIGURE 8 DATA TRIANGULATION METHODOLOGY
2.5 ASSUMPTIONS FOR THE STUDY
2.6 RISK ASSESSMENT
TABLE 1 RISK ASSESSMENT: CLINICAL DECISION SUPPORT SYSTEMS MARKET
2.7 LIMITATIONS
3 EXECUTIVE SUMMARY (Page No. – 39)
FIGURE 9 CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COMPONENT, 2022 VS. 2027 (USD MILLION)
FIGURE 10 CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY PRODUCT, 2022 VS. 2027 (USD MILLION)
FIGURE 11 CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY TYPE, 2022 VS. 2027 (USD MILLION)
FIGURE 12 CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY MODEL, 2022 VS. 2027 (USD MILLION)
FIGURE 13 CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY APPLICATION, 2022 VS. 2027 (USD MILLION)
FIGURE 14 CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY DELIVERY MODE, 2022 VS. 2027 (USD MILLION)
FIGURE 15 CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY INTERACTIVITY LEVEL, 2022 VS. 2027 (USD MILLION)
FIGURE 16 CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY SETTING, 2022 VS. 2027 (USD MILLION)
FIGURE 17 GEOGRAPHICAL SNAPSHOT OF THE CLINICAL DECISION SUPPORT SYSTEMS MARKET
4 PREMIUM INSIGHTS (Page No. – 46)
4.1 CLINICAL DECISION SUPPORT SYSTEMS MARKET OVERVIEW
FIGURE 18 RISING GOVERNMENT INITIATIVES FOR THE ADOPTION OF HCIT SOLUTIONS DRIVE THE MARKET GROWTH
4.2 NORTH AMERICA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY PRODUCT AND COUNTRY
FIGURE 19 US DOMINATED THE MARKET IN NORTH AMERICA (2021)
4.3 CLINICAL DECISION SUPPORT SYSTEMS MARKET SHARE, BY PRODUCT
FIGURE 20 INTEGRATED CDSS SEGMENT TO DOMINATE THE MARKET FROM 2022 TO 2027
4.4 CLINICAL DECISION SUPPORT SYSTEMS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
FIGURE 21 ASIA PACIFIC TO WITNESS THE HIGHEST GROWTH DURING THE FORECAST PERIOD
5 MARKET OVERVIEW (Page No. – 49)
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
FIGURE 22 CLINICAL DECISION SUPPORT SYSTEMS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
5.2.1 DRIVERS
5.2.1.1 Implementation of government regulations & initiatives to promote the adoption of HCIT solutions
5.2.1.2 Increasing adoption of CDSS-enabled EHRs
5.2.1.3 Growing collaborations & partnerships among stakeholders
TABLE 2 INDICATIVE LIST OF COLLABORATIONS BETWEEN ORGANIZATIONS FROM 2020 TO 2022
5.2.1.4 Growing incidence of medication errors
5.2.1.5 Development of big data and mHealth tools
5.2.2 RESTRAINTS
5.2.2.1 Data security concerns related to cloud-based CDSS
5.2.2.2 Inadequate interoperability
5.2.3 OPPORTUNITIES
5.2.3.1 The growth potential of emerging markets
5.2.3.2 Social media integration and rising technological advancements
5.2.4 CHALLENGES
5.2.4.1 Requirement of high investments for the implementation of CDSS infrastructure
5.2.4.2 Shortage of skilled IT professionals in the healthcare industry
5.3 IMPACT OF COVID-19 ON THE CLINICAL DECISION SUPPORT SYSTEMS MARKET
5.4 VALUE-CHAIN ANALYSIS
FIGURE 23 CLINICAL DECISION SUPPORT SYSTEMS MARKET: VALUE-CHAIN ANALYSIS (2021)
5.5 CASE STUDIES
5.5.1 IMPROVING RESPONSE PHYSICIAN EFFICIENCY AND TIME
TABLE 3 CASE 1: NEED TO PROVIDE BETTER FACILITIES
5.5.2 IMPROVING EFFICIENCY AND CARE WITH AI
TABLE 4 CASE 2: IMPROVING EFFICIENCY, ADOPTION, AND CARE EXPERIENCES WITH AI-POWERED CDS
5.5.3 PROVIDING THE BEST PATIENT CARE
TABLE 5 CASE 3: FOCUS ON QUALITY AND SAFETY
5.6 ECOSYSTEM ANALYSIS
FIGURE 24 CLINICAL DECISION SUPPORT SYSTEM MARKET: ECO SYSTEM ANALYSIS (2021)
5.7 TECHNOLOGY ANALYSIS
TABLE 6 TECHNOLOGICAL DEVELOPMENTS BY LEADING VENDORS
5.8 REGULATORY ANALYSIS
5.8.1 HEALTH INSURANCE PORTABILITY AND ACCOUNTABILITY ACT OF 1996 (HIPAA)
5.8.2 HEALTH INFORMATION TECHNOLOGY FOR ECONOMIC AND CLINICAL HEALTH ACT OF 2009 (HITECH)
5.8.3 CONSUMER PRIVACY PROTECTION ACT OF 2017
5.8.4 NATIONAL CYBERSECURITY PROTECTION ADVANCEMENT ACT OF 2015
5.8.5 CYBERSECURITY LAW OF THE PEOPLE’S REPUBLIC OF CHINA
5.8.6 AFFORDABLE CARE ACT, 2010
5.9 PORTER’S FIVE FORCES ANALYSIS
TABLE 7 CDSS MARKET: PORTER’S FIVE FORCES ANALYSIS
5.10 INDUSTRY TRENDS
5.10.1 RISING NEED FOR INTEROPERABILITY & INTEGRATION FOR HCIT SOLUTIONS
5.10.2 GRADUAL SHIFT OF ACCOUNTABILITY FROM PAYERS TO PROVIDERS
5.10.3 GROWING DEMAND FOR VALUE-BASED HEALTHCARE
5.11 PRICING ANALYSIS
TABLE 8 AVERAGE SELLING PRICE OF CDSS SOLUTIONS, BY PRODUCT (2021)
5.12 CONFERENCES AND WEBINARS
5.13 BUSINESS MODELS
FIGURE 25 BENEFITS OF HYBRID BUSINESS MODELS
6 CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COMPONENT (Page No. – 66)
6.1 INTRODUCTION
TABLE 9 CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COMPONENT, 2020–2027 (USD MILLION)
6.2 SERVICES
6.2.1 SERVICES SEGMENT TO DOMINATE THE MARKET FROM 2022–2027
TABLE 10 CLINICAL DECISION SUPPORT SERVICES MARKET, BY REGION, 2020–2027 (USD MILLION)
6.3 SOFTWARE
6.3.1 THE USE OF EMR/EHR-INTEGRATED CDSS ENABLES ACCESS TO CENTRALIZED PATIENT DATABASES
TABLE 11 CLINICAL DECISION SUPPORT SOFTWARE MARKET, BY REGION, 2020–2027 (USD MILLION)
6.4 HARDWARE
6.4.1 HARDWARE MUST BE FREQUENTLY UPGRADED OR REPLACED FOR THE OPTIMAL USE OF ADVANCED SOFTWARE
TABLE 12 CLINICAL DECISION SUPPORT HARDWARE MARKET, BY REGION, 2020–2027 (USD MILLION)
7 CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY PRODUCT (Page No. – 71)
7.1 INTRODUCTION
TABLE 13 CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
7.2 INTEGRATED CDSS
7.2.1 INTEGRATED CDSS IS WIDELY USED BY HEALTHCARE PROVIDERS TO IMPROVE THE QUALITY OF CARE AND REDUCE MEDICATION ERRORS
TABLE 14 INTEGRATED CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY REGION, 2020–2027 (USD MILLION)
7.3 STANDALONE CDSS
7.3.1 LACK OF INTEROPERABILITY WITH CPOE AND EHR TO RESTRAIN THE MARKET DEMAND
TABLE 15 STANDALONE CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY REGION, 2020–2027 (USD MILLION)
8 CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY TYPE (Page No. – 75)
8.1 INTRODUCTION
TABLE 16 CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
8.2 THERAPEUTIC CDSS
8.2.1 THERAPEUTIC CDSS IS MOST EFFECTIVE IN INTEGRATED CLINICAL WORKFLOWS AS IT REDUCES MEDICATION ERRORS
TABLE 17 THERAPEUTIC CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY REGION, 2020–2027 (USD MILLION)
8.3 DIAGNOSTIC CDSS
8.3.1 DIAGNOSTIC CDSS GUIDES PHYSICIANS THROUGH A SYSTEMATIC DIAGNOSIS PROCESS
TABLE 18 DIAGNOSTIC CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY REGION, 2020–2027 (USD MILLION)
9 CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY MODEL (Page No. – 78)
9.1 INTRODUCTION
TABLE 19 CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY MODEL, 2020–2027 (USD MILLION)
9.2 KNOWLEDGE-BASED CDSS
9.2.1 KNOWLEDGE-BASED CDSS MODELS USE CONDITIONAL LOGIC FOR DECISION-MAKING AND PROBLEM ANALYSIS
TABLE 20 KNOWLEDGE-BASED CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY REGION, 2020–2027 (USD MILLION)
9.3 NON-KNOWLEDGE-BASED CDSS
9.3.1 NON-KNOWLEDGE-BASED CDSS IMPLEMENTS ML AND AI ALGORITHMS TO EXPAND ITS USER-DEFINED KNOWLEDGE BASE
TABLE 21 NON-KNOWLEDGE-BASED CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY REGION, 2020–2027 (USD MILLION)
10 CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY DELIVERY MODE (Page No. – 82)
10.1 INTRODUCTION
TABLE 22 CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY DELIVERY MODE, 2020–2027 (USD MILLION)
10.2 ON-PREMISE CDSS
10.2.1 LICENSED SOFTWARE IS INSTALLED ON ON-PREMISE CDSS DELIVERY MODES
TABLE 23 ON-PREMISE CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY REGION, 2020–2027 (USD MILLION)
10.3 CLOUD-BASED CDSS
10.3.1 CLOUD-BASED CDSS IS PROJECTED TO GROW AT THE HIGHEST RATE DURING THE FORECAST PERIOD
TABLE 24 CLOUD-BASED CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY REGION, 2020–2027 (USD MILLION)
11 CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY APPLICATION (Page No. – 86)
11.1 INTRODUCTION
TABLE 25 CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
11.2 CONVENTIONAL CDSS
11.2.1 CONVENTIONAL CDSS IS USED TO ENHANCE HEALTH-RELATED DECISION-MAKING
TABLE 26 CONVENTIONAL CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY REGION, 2020–2027 (USD MILLION)
11.3 ADVANCED CDSS
11.3.1 ADVANCED CDSS SEGMENT TO WITNESS HIGH GROWTH DURING THE FORECAST PERIOD
TABLE 27 ADVANCED CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY REGION, 2020–2027 (USD MILLION)
12 CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY INTERACTIVITY LEVEL (Page No. – 90)
12.1 INTRODUCTION
TABLE 28 CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY INTERACTIVITY LEVEL, 2020–2027 (USD MILLION)
12.2 ACTIVE CDSS
12.2.1 ACTIVE CDSS IS THE LARGEST AND THE FASTEST-GROWING SEGMENT IN THE CDSS MARKET
TABLE 29 ACTIVE CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY REGION, 2020–2027 (USD MILLION)
12.3 PASSIVE CDSS
12.3.1 PASSIVE CDSS CAUSES MINIMAL DISRUPTION TO WORKFLOWS
TABLE 30 PASSIVE CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY REGION, 2020–2027 (USD MILLION)
13 CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY SETTING (Page No. – 94)
13.1 INTRODUCTION
TABLE 31 CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY SETTING, 2020–2027 (USD MILLION)
13.2 INPATIENT SETTINGS
13.2.1 THE ADOPTION OF CDSS FOR INPATIENT SETTINGS HELPS IMPROVE PATIENT CARE WORKFLOWS
TABLE 32 CLINICAL DECISION SUPPORT SYSTEMS MARKET FOR INPATIENT SETTINGS, BY REGION, 2020–2027 (USD MILLION)
13.3 AMBULATORY CARE SETTINGS
13.3.1 THE RISING NEED TO CONTROL HEALTHCARE COSTS DRIVES THE DEMAND FOR CDSS IN AMBULATORY CARE SETTINGS
TABLE 33 CLINICAL DECISION SUPPORT SYSTEMS MARKET FOR AMBULATORY CARE SETTINGS, BY REGION, 2020–2027 (USD MILLION)
14 CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY REGION (Page No. – 98)
14.1 INTRODUCTION
FIGURE 26 NORTH AMERICA TO DOMINATE THE CDSS MARKET FROM 2022 TO 2027
TABLE 34 CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY REGION, 2020–2027 (USD MILLION)
14.2 NORTH AMERICA
FIGURE 27 NORTH AMERICA: CDSS MARKET SNAPSHOT
TABLE 35 NORTH AMERICA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 36 NORTH AMERICA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COMPONENT, 2020–2027 (USD MILLION)
TABLE 37 NORTH AMERICA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY DELIVERY MODE, 2020–2027 (USD MILLION)
TABLE 38 NORTH AMERICA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 39 NORTH AMERICA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 40 NORTH AMERICA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY MODEL, 2020–2027 (USD MILLION)
TABLE 41 NORTH AMERICA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY INTERACTIVITY LEVEL, 2020–2027 (USD MILLION)
TABLE 42 NORTH AMERICA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 43 NORTH AMERICA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY SETTING, 2020–2027 (USD MILLION)
14.2.1 US
14.2.1.1 The US is the largest market for CDSS solutions
TABLE 44 US: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COMPONENT, 2020–2027 (USD MILLION)
TABLE 45 US: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY DELIVERY MODE, 2020–2027 (USD MILLION)
TABLE 46 US: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 47 US: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 48 US: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY MODEL, 2020–2027 (USD MILLION)
TABLE 49 US: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY INTERACTIVITY LEVEL, 2020–2027 (USD MILLION)
TABLE 50 US: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 51 US: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY SETTING, 2020–2027 (USD MILLION)
14.2.2 CANADA
14.2.2.1 The rising requirement for cost containment drives the market growth in Canada
TABLE 52 CANADA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COMPONENT, 2020–2027 (USD MILLION)
TABLE 53 CANADA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY DELIVERY MODE, 2020–2027 (USD MILLION)
TABLE 54 CANADA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 55 CANADA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 56 CANADA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY MODEL, 2020–2027 (USD MILLION)
TABLE 57 CANADA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY INTERACTIVITY LEVEL, 2020–2027 (USD MILLION)
TABLE 58 CANADA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 59 CANADA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY SETTING, 2020–2027 (USD MILLION)
14.3 EUROPE
TABLE 60 EUROPE: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 61 EUROPE: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COMPONENT, 2020–2027 (USD MILLION)
TABLE 62 EUROPE: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY DELIVERY MODE, 2020–2027 (USD MILLION)
TABLE 63 EUROPE: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 64 EUROPE: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 65 EUROPE: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY MODEL, 2020–2027 (USD MILLION)
TABLE 66 EUROPE: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY INTERACTIVITY LEVEL, 2020–2027 (USD MILLION)
TABLE 67 EUROPE: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 68 EUROPE: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY SETTING, 2020–2027 (USD MILLION)
14.3.1 GERMANY
14.3.1.1 Government initiatives to boost the adoption of EMRs drives the market growth in Germany
TABLE 69 GERMANY: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COMPONENT, 2020–2027 (USD MILLION)
TABLE 70 GERMANY: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY DELIVERY MODE, 2020–2027 (USD MILLION)
TABLE 71 GERMANY: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 72 GERMANY: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 73 GERMANY: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY MODEL, 2020–2027 (USD MILLION)
TABLE 74 GERMANY: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY INTERACTIVITY LEVEL, 2020–2027 (USD MILLION)
TABLE 75 GERMANY: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 76 GERMANY: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY SETTING, 2020–2027 (USD MILLION)
14.3.2 UK
14.3.2.1 Favorable government initiatives drive the demand for CDSS solutions in the UK
TABLE 77 UK: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COMPONENT, 2020–2027 (USD MILLION)
TABLE 78 UK: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY DELIVERY MODE, 2020–2027 (USD MILLION)
TABLE 79 UK: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 80 UK: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 81 UK: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY MODEL, 2020–2027 (USD MILLION)
TABLE 82 UK: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY INTERACTIVITY LEVEL, 2020–2027 (USD MILLION)
TABLE 83 UK: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 84 UK: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY SETTING, 2020–2027 (USD MILLION)
14.3.3 FRANCE
14.3.3.1 The rising focus on improving the healthcare system in France drives the market demand for CDSS
TABLE 85 FRANCE: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COMPONENT, 2020–2027 (USD MILLION)
TABLE 86 FRANCE: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY DELIVERY MODE, 2020–2027 (USD MILLION)
TABLE 87 FRANCE: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 88 FRANCE: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 89 FRANCE: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY MODEL, 2020–2027 (USD MILLION)
TABLE 90 FRANCE: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY INTERACTIVITY LEVEL, 2020–2027 (USD MILLION)
TABLE 91 FRANCE: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 92 FRANCE: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY SETTING, 2020–2027 (USD MILLION)
14.3.4 ITALY
14.3.4.1 The growing burden of chronic diseases drives the adoption of EHR solutions in Italy
TABLE 93 ITALY: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COMPONENT, 2020–2027 (USD MILLION)
TABLE 94 ITALY: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY DELIVERY MODE, 2020–2027 (USD MILLION)
TABLE 95 ITALY: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 96 ITALY: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 97 ITALY: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY MODEL, 2020–2027 (USD MILLION)
TABLE 98 ITALY: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY INTERACTIVITY LEVEL, 2020–2027 (USD MILLION)
TABLE 99 ITALY: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 100 ITALY: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY SETTING, 2020–2027 (USD MILLION)
14.3.5 SPAIN
14.3.5.1 Growing cases of COVID-19 have driven the demand for evidence-based solutions in Spain
TABLE 101 SPAIN: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COMPONENT, 2020–2027 (USD MILLION)
TABLE 102 SPAIN: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY DELIVERY MODE, 2020–2027 (USD MILLION)
TABLE 103 SPAIN: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 104 SPAIN: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 105 SPAIN: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY MODEL, 2020–2027 (USD MILLION)
TABLE 106 SPAIN: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY INTERACTIVITY LEVEL, 2020–2027 (USD MILLION)
TABLE 107 SPAIN: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 108 SPAIN: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY SETTING, 2020–2027 (USD MILLION)
14.3.6 REST OF EUROPE
TABLE 109 ROE: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COMPONENT, 2020–2027 (USD MILLION)
TABLE 110 ROE: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY DELIVERY MODE, 2020–2027 (USD MILLION)
TABLE 111 ROE: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 112 ROE: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 113 ROE: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY MODEL, 2020–2027 (USD MILLION)
TABLE 114 ROE: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY INTERACTIVITY LEVEL, 2020–2027 (USD MILLION)
TABLE 115 ROE: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 116 ROE: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY SETTING, 2020–2027 (USD MILLION)
14.4 ASIA PACIFIC
FIGURE 28 ASIA PACIFIC: CDSS MARKET SNAPSHOT
TABLE 117 ASIA PACIFIC: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 118 ASIA PACIFIC: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COMPONENT, 2020–2027 (USD MILLION)
TABLE 119 ASIA PACIFIC: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY DELIVERY MODE, 2020–2027 (USD MILLION)
TABLE 120 ASIA PACIFIC: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 121 ASIA PACIFIC: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 122 ASIA PACIFIC: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY MODEL, 2020–2027 (USD MILLION)
TABLE 123 ASIA PACIFIC: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY INTERACTIVITY LEVEL, 2020–2027 (USD MILLION)
TABLE 124 ASIA PACIFIC: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 125 ASIA PACIFIC: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY SETTING, 2020–2027 (USD MILLION)
14.4.1 JAPAN
14.4.1.1 The rising geriatric population in Japan supports the adoption of evidence-based clinical decisions using CDSS
TABLE 126 JAPAN: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COMPONENT, 2020–2027 (USD MILLION)
TABLE 127 JAPAN: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY DELIVERY MODE, 2020–2027 (USD MILLION)
TABLE 128 JAPAN: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 129 JAPAN: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 130 JAPAN: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY MODEL, 2020–2027 (USD MILLION)
TABLE 131 JAPAN: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY INTERACTIVITY LEVEL, 2020–2027 (USD MILLION)
TABLE 132 JAPAN: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 133 JAPAN: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY SETTING, 2020–2027 (USD MILLION)
14.4.2 CHINA
14.4.2.1 China is a lucrative market for HCIT solutions due to strong government support for healthcare reforms
TABLE 134 CHINA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COMPONENT, 2020–2027 (USD MILLION)
TABLE 135 CHINA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY DELIVERY MODE, 2020–2027 (USD MILLION)
TABLE 136 CHINA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 137 CHINA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 138 CHINA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY MODEL, 2020–2027 (USD MILLION)
TABLE 139 CHINA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY INTERACTIVITY LEVEL, 2020–2027 (USD MILLION)
TABLE 140 CHINA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 141 CHINA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY SETTING, 2020–2027 (USD MILLION)
14.4.3 INDIA
14.4.3.1 The high burden of chronic diseases in India supports the market adoption of CDSS-based solutions
TABLE 142 INDIA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COMPONENT, 2020–2027 (USD MILLION)
TABLE 143 INDIA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY DELIVERY MODE, 2020–2027 (USD MILLION)
TABLE 144 INDIA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 145 INDIA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 146 INDIA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY MODEL, 2020–2027 (USD MILLION)
TABLE 147 INDIA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY INTERACTIVITY LEVEL, 2020–2027 (USD MILLION)
TABLE 148 INDIA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 149 INDIA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY SETTING, 2020–2027 (USD MILLION)
14.4.4 REST OF ASIA PACIFIC (ROAPAC)
TABLE 150 ROAPAC: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COMPONENT, 2020–2027 (USD MILLION)
TABLE 151 ROAPAC: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY DELIVERY MODE, 2020–2027 (USD MILLION)
TABLE 152 ROAPAC: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 153 ROAPAC: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 154 ROAPAC: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY MODEL, 2020–2027 (USD MILLION)
TABLE 155 ROAPAC: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY INTERACTIVITY LEVEL, 2020–2027 (USD MILLION)
TABLE 156 ROAPAC: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 157 ROAPAC: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY SETTING, 2020–2027 (USD MILLION)
14.5 REST OF THE WORLD
TABLE 158 ROW: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY REGION, 2020–2027 (USD MILLION)
TABLE 159 ROW: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COMPONENT, 2020–2027 (USD MILLION)
TABLE 160 ROW: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY DELIVERY MODE, 2020–2027 (USD MILLION)
TABLE 161 ROW: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 162 ROW: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 163 ROW: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY MODEL, 2020–2027 (USD MILLION)
TABLE 164 ROW: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY INTERACTIVITY LEVEL, 2020–2027 (USD MILLION)
TABLE 165 ROW: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 166 ROW: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY SETTING, 2020–2027 (USD MILLION)
14.5.1 LATIN AMERICA
14.5.1.1 Developments in healthcare infrastructure support the market growth in Latin America
TABLE 167 LATIN AMERICA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COMPONENT, 2020–2027 (USD MILLION)
TABLE 168 LATIN AMERICA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY DELIVERY MODE, 2020–2027 (USD MILLION)
TABLE 169 LATIN AMERICA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 170 LATIN AMERICA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 171 LATIN AMERICA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY MODEL, 2020–2027 (USD MILLION)
TABLE 172 LATIN AMERICA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY INTERACTIVITY LEVEL, 2020–2027 (USD MILLION)
TABLE 173 LATIN AMERICA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 174 LATIN AMERICA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY SETTING, 2020–2027 (USD MILLION)
14.5.2 MIDDLE EAST & AFRICA
14.5.2.1 Growing medical tourism supports the market adoption of CDSS in the Middle East & Africa
TABLE 175 MIDDLE EAST & AFRICA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COMPONENT, 2020–2027 (USD MILLION)
TABLE 176 MIDDLE EAST & AFRICA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY DELIVERY MODE, 2020–2027 (USD MILLION)
TABLE 177 MIDDLE EAST & AFRICA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 178 MIDDLE EAST & AFRICA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 179 MIDDLE EAST & AFRICA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY MODEL, 2020–2027 (USD MILLION)
TABLE 180 MIDDLE EAST & AFRICA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY INTERACTIVITY LEVEL, 2020–2027 (USD MILLION)
TABLE 181 MIDDLE EAST & AFRICA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 182 MIDDLE EAST & AFRICA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY SETTING, 2020–2027 (USD MILLION)
15 COMPETITIVE LANDSCAPE (Page No. – 160)
15.1 OVERVIEW
15.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
TABLE 183 OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN THE CLINICAL DECISION SUPPORT SYSTEMS MARKET
15.3 REVENUE SHARE ANALYSIS OF THE TOP MARKET PLAYERS
FIGURE 29 REVENUE ANALYSIS OF KEY PLAYERS IN THE CLINICAL DECISION SUPPORT SYSTEMS MARKET
15.4 MARKET RANKING OF PLAYERS, 2021
FIGURE 30 CLINICAL DECISION SUPPORT SYSTEMS MARKET RANKING, BY KEY PLAYER, 2021
15.5 COMPETITIVE BENCHMARKING
TABLE 184 CLINICAL DECISION SUPPORT SYSTEMS MARKET: COMPETITIVE BENCHMARKING OF KEY PLAYERS
TABLE 185 CLINICAL DECISION SUPPORT SYSTEMS MARKET: APPLICATION & PRODUCT FOOTPRINT OF KEY PLAYERS
TABLE 186 CLINICAL DECISION SUPPORT SYSTEMS MARKET: REGIONAL FOOTPRINT OF KEY PLAYERS
15.6 COMPETITIVE LEADERSHIP MAPPING
15.6.1 STARS
15.6.2 EMERGING LEADERS
15.6.3 PERVASIVE PLAYERS
15.6.4 PARTICIPANTS
FIGURE 31 CLINICAL DECISION SUPPORT SYSTEMS MARKET (GLOBAL) COMPANY EVALUATION MATRIX, 2021
15.7 COMPETITIVE LEADERSHIP MAPPING – START-UPS/SMES
15.7.1 PROGRESSIVE COMPANIES
15.7.2 STARTING BLOCKS
15.7.3 RESPONSIVE COMPANIES
15.7.4 DYNAMIC COMPANIES
FIGURE 32 COMPETITIVE LEADERSHIP MAPPING, START-UP/SME MATRIX MARKET
15.8 COMPETITIVE SITUATIONS AND TRENDS
TABLE 187 PRODUCT LAUNCHES/ENHANCEMENTS
15.8.1 DEALS
TABLE 188 DEALS, JANUARY 2019–MAY 2022
16 COMPANY PROFILES (Page No. – 180)
(Business overview, Products & services offered, Recent developments & MnM View)*
16.1 KEY PLAYERS
16.1.1 CERNER CORPORATION
TABLE 189 CERNER: BUSINESS OVERVIEW
FIGURE 33 CERNER CORPORATION: COMPANY SNAPSHOT (2019)
16.1.2 IBM WATSON HEALTH
TABLE 190 IBM: BUSINESS OVERVIEW
FIGURE 34 IBM: COMPANY SNAPSHOT (2021)
16.1.3 CHANGE HEALTHCARE
TABLE 191 CHANGE HEALTHCARE: BUSINESS OVERVIEW
FIGURE 35 CHANGE HEALTHCARE: COMPANY SNAPSHOT (2021)
16.1.4 ALLSCRIPTS HEALTHCARE SOLUTIONS, INC.
TABLE 192 ALLSCRIPTS HEALTHCARE SOLUTIONS, INC.: BUSINESS OVERVIEW
FIGURE 36 ALLSCRIPTS HEALTHCARE, LLC: COMPANY SNAPSHOT (2021)
16.1.5 ATHENAHEALTH
TABLE 193 ATHENAHEALTH: BUSINESS OVERVIEW
16.1.6 EPIC SYSTEMS CORPORATION
TABLE 194 EPIC SYSTEMS CORPORATION: BUSINESS OVERVIEW
16.1.7 ELSEVIER B.V. (A DIVISION OF RELX GROUP)
TABLE 195 ELSEVIER B.V.: BUSINESS OVERVIEW
16.1.8 ZYNX HEALTH
TABLE 196 ZYNX HEALTH: BUSINESS OVERVIEW
16.1.9 WOLTERS KLUWER N.V.
TABLE 197 WOLTERS KLUWER N.V.: BUSINESS OVERVIEW
FIGURE 37 WOLTERS KLUWER N.V.: COMPANY SNAPSHOT (2021)
16.1.10 PHILIPS HEALTHCARE (A SUBSIDIARY OF ROYAL PHILIPS)
TABLE 198 PHILIPS HEALTHCARE: BUSINESS OVERVIEW
FIGURE 38 PHILIPS HEALTHCARE: COMPANY SNAPSHOT (2021)
16.1.11 MEDITECH
TABLE 199 MEDITECH: BUSINESS OVERVIEW
*Details on Business overview, Products & services offered, Recent developments & MnM View might not be captured in case of unlisted companies.
16.2 OTHER KEY PLAYERS
16.2.1 NEXTGEN HEALTHCARE
16.2.2 SIEMENS HEALTHINEERS
16.2.3 EBSCO HEALTH (A DIVISION OF EBSCO INDUSTRIES, INC.)
16.2.4 GE HEALTHCARE
16.2.5 ECLINICALWORKS
16.2.6 RAMPMEDICAL
16.2.7 THE MEDICAL ALGORITHMS COMPANY
16.2.8 HERA-MI
16.2.9 CUREMD
16.2.10 CARECLOUD
16.2.11 VISUALDX
16.2.12 STANSON HEALTH
16.2.13 FIRST DATABANK
16.2.14 STRATA DECISION TECHNOLOGY
17 APPENDIX (Page No. – 224)
17.1 DISCUSSION GUIDE
17.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
17.3 AVAILABLE CUSTOMIZATIONS
17.4 RELATED REPORTS
17.5 AUTHOR DETAILS
